Bucking the trend of IL-12 therapy program failures, Imunon’s IMNN-001 was bolstered by positive translational data in ovarian cancer.

IMUNON (IMNN) announced that new translational data from the Phase 2 OVATION 2 Study of IMNN-001, its investigational therapy for the treatment of ...

Development of nonviral delivery systems is progressing toward a transfection efficiency sufficient to affect metabolic and neoplastic diseases in humans. Nevertheless, inadequate transfection ...

Plasmid DNA can be used across an extensive range of applications. Therefore, ensuring the supply is purified in the right way is crucial for every given situation. Analytik Jena‘s CyBio FeliX Liquid ...

Adeno-associated viruses (AAV) have emerged as pivotal delivery vehicles for gene therapy due to their overall safety (less immunogenic), efficiency (broad tropism), and long-term gene expression.

OVATION 3 pivotal Phase 3 trial is currently advancing IMNN-001, with several patients being treatedLAWRENCEVILLE, N.J., Sept (GLOBE ...